FibroBiologics Announces Preliminary Proof of Concept for Fibroblast-based Diabetes Treatment

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/1/2026

1. NVDA
2. PCG
3. AMZN
4. AAPL
5. AVGO
6. STLA
7. EC
8. ALNY
9. CNS
10. ATTO

Go back to FibroBiologics Announces Preliminary Proof of Concept for Fibroblast-based Diabetes Treatment
(NASDAQ: FBLG) Delayed: 1.72 +0.28 (19.44%)
Previous Close $1.44    52 Week High $ 
Open $1.46    52 Week Low $ 
Day High $1.79    P/E N/A 
Day Low $1.40    EPS $ 
Volume 508,059